Skip to main content
    T

    Trevi Therapeutics Inc (TRVI)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $13.29
    -0.36 (-2.64%)

    Market Cap: $1.95B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Trevi Therapeutics Inc (TRVI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Trevi Therapeutics are Vera Therapeutics (VERA), Biohaven (BHVN) and Travere Therapeutics (TVTX). By market cap, Trevi Therapeutics ranks 7th of the 13 companies on this page; Travere Therapeutics (TVTX) is the largest at $4.86B. The median P/E of the 4 companies with a P/E is 16.2x.

    Peer Comparison

    TRVI's revenue growth of 0.0% is above the peer median of -0.7%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Trevi Therapeutics (TRVI)$1.95BN/AN/A0.0%N/A0.0%0.00%
    Vera Therapeutics Inc (VERA)$2.03BN/A189.3x0.0%-83.0%0.0%0.00%
    Biohaven Ltd. (BHVN)$2.09BN/AN/A0.0%-315.9%0.0%0.00%
    Travere Therapeutics Inc (TVTX)$4.86BN/A7.2x-18.7%-23.1%36.2%0.00%
    Structure Therapeutics Inc. American Depositary Shares (GPCR)$1.43BN/AN/A0.0%N/A0.0%0.00%
    Vir Biotechnology Inc (VIR)$1.71BN/A5.4x-61.0%N/A19582.0%0.00%
    Beam Therapeutics Inc (BEAM)$2.36BN/A15.0x-73.9%-29.7%-96.8%0.00%
    Fortrea Holdings Inc. (FTRE)$1.95B26.0x0.7x-2.6%1.8%-1.4%0.00%
    Theravance Biopharma Inc (TBPH)$884.18M95.1x8.4x51.6%N/A-20.9%0.00%
    Viridian Therapeutics Inc (VRDN)$3.51BN/A128.5x0.0%-41.8%-63.5%0.00%
    Nurix Therapeutics Inc (NRIX)$1.69B6.4x2.3x42.0%N/A8426.0%0.00%
    Ocular Therapeutix Inc (OCUL)$1.37BN/A26.9x0.0%-52.1%-11.5%0.00%
    Innoviva Inc (INVA)$1.35B5.3x3.0x44.1%10.8%-1.6%0.00%
    Peer median$1.83B16.2x7.8x0.0%-35.7%-0.7%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Trevi Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Vera Therapeutics Inc (VERA)
    Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases...
    VERA competitors
    Biohaven Ltd. (BHVN)
    Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders...
    BHVN competitors
    Travere Therapeutics Inc (TVTX)
    Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification...
    TVTX competitors
    Structure Therapeutics Inc. American Depositary Shares (GPCR)
    Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic...
    GPCR competitors
    Vir Biotechnology Inc (VIR)
    Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases.
    VIR competitors
    Beam Therapeutics Inc (BEAM)
    Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States.
    BEAM competitors
    Fortrea Holdings Inc. (FTRE)
    Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry.
    FTRE competitors
    Theravance Biopharma Inc (TBPH)
    Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe...
    Viridian Therapeutics Inc (VRDN)
    Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses.
    VRDN competitors
    Nurix Therapeutics Inc (NRIX)
    Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development...
    NRIX competitors
    Ocular Therapeutix Inc (OCUL)
    Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development...
    OCUL competitors
    Innoviva Inc (INVA)
    Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.
    INVA competitors

    Frequently Asked Questions About TRVI

    Who are Trevi Therapeutics' main competitors?

    The companies most similar to Trevi Therapeutics include Vera Therapeutics (VERA), Biohaven (BHVN), Travere Therapeutics (TVTX), Structure Therapeutics Inc. American Depositary Shares (GPCR) and Vir Biotechnology (VIR), listed from the closest match.

    Who is Trevi Therapeutics' biggest competitor?

    Travere Therapeutics (TVTX) is the largest of the similar companies at $4.86B; Vera Therapeutics (VERA) is the closest match by business profile, size, sector and industry.

    How does TRVI stock compare with its competitors?

    TRVI's net margin is 0.0% against a peer median of 0.0%.

    Which of Trevi Therapeutics' competitors pays a higher dividend?

    Trevi Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Trevi Therapeutics bigger than its competitors?

    No. Trevi Therapeutics is 7th by market cap among the 13 companies on this page; the largest is Travere Therapeutics (TVTX) at $4.86B.